Lycorine suppresses hepatocellular carcinoma via the reprogramming of myeloid and epithelial cells
Phytomedicine · 2026
DOI: 10.1016/j.phymed.2025.157657 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2026. Verfasst von Xinyu Gu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Henan Key Laboratory of Cancer Epigenetics, Cancer Institute, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Scienc…. Hauptthemen laut MEDLINE: Amaryllidaceae Alkaloids, Phenanthridines, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit nennt 62 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
BACKGROUND: Hepatocellular carcinoma (HCC) is an aggressive malignancy associated with an immunosuppressive tumor microenvironment (TME), which contributes to resistance to therapy. Lycorine, a natural alkaloid, has demonstrated anticancer potential, but its effects on HCC remain insufficiently explored. PURPOSE: This study aimed to systematically assess the impact of lycorine on HCC and elucidate its underlying mechanisms of action. STUDY DESIGN: In vivo orthotopic HCC mouse models were employed, incorporating high-dimensional single-cell techniques to comprehensively analyze the effects of lycorine on the TME. METHODS: Mice bearing orthotopic HCC tumors were treated with lycorine at doses of 10 or 20 mg/kg for 14 days. Tumor progression was assessed by measuring tumor weight. The immune landscape was examined using cytometry by time of flight (CyTOF), and cellular heterogeneity was evaluated via single-cell RNA sequencing (scRNA-seq). Cell-cell communication networks were reconstructed through CellChat analysis. RESULTS: Lycorine treatment significantly reduced tumor burden and modulated cytokine expression profiles. CyTOF analysis revealed that lycorine reprogrammed the immune landscape, enhancing macrophage and neutrophil infiltration while decreasing PD-L1 expression on neutrophils. scRNA-seq analysis indicated that lycorine regulated specific cell subpopulations, including malignant epithelial cells, Notch2+ neutrophils, and Spp1+ macrophages. Cell-cell communication analysis identified the regulation of the Mif-(Cd74+Cd44/Cxcr4) signaling axis as a key underlying mechanism. CONCLUSION: Lycorine remodels the HCC TME through coordinated actions on malignant epithelial cells and immune populations, notably neutrophil and macrophage subpopulations. These findings support the potential development of lycorine-based combination therapies for HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Henan Key Laboratory of Cancer Epigenetics, Cancer Institute, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang 471003, Henan, China.
- Department of Integrated Traditional and Western Medicine, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang 471003, Henan, China.
- Department of Infectious Diseases, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang 471000, Henan, China; Henan Medical Key Laboratory of Gastrointestinal…
- Department of Integrated Traditional and Western Medicine, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang 471003, Henan, China. Electronic address: a8767…
- State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Di…
Förderung
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Gu, X., Ma, F., Liu, Y., Zhang, S., Chen, W., Zhang, L., Zhang, L., Lu, J., & Hu, X. (2026). Lycorine suppresses hepatocellular carcinoma via the reprogramming of myeloid and epithelial cells. Phytomedicine. https://doi.org/10.1016/j.phymed.2025.157657
Vancouver
Gu X, Ma F, Liu Y, Zhang S, Chen W, Zhang L, et al. Lycorine suppresses hepatocellular carcinoma via the reprogramming of myeloid and epithelial cells. Phytomedicine. 2026. doi:10.1016/j.phymed.2025.157657
BibTeX
@article{Gu2026,
author = {Gu, Xinyu and Ma, Fuqiang and Liu, Yafeng and Zhang, Shujun and Chen, Wenjuan and Zhang, Lifan and Zhang, Lele and Lu, Juan and Hu, Xinjun},
title = {Lycorine suppresses hepatocellular carcinoma via the reprogramming of myeloid and epithelial cells},
journal = {Phytomedicine},
year = {2026},
doi = {10.1016/j.phymed.2025.157657}
}
EUVIMED